Ocular pharmacology involves the study of drugs and their effects on the eyes. Pharmacodynamics in ocular pharmacology focuses on how drugs interact with ocular tissues to produce their therapeutic effects. The pharmacodynamic properties of ocular drugs are crucial in understanding their mechanisms of action, including how they affect receptors and signalling pathways within the eye.
For example, drugs targeting the ciliary muscle can alter the shape of the lens, influencing accommodation and addressing conditions like myopia or hyperopia. Glaucoma medications often target intraocular pressure by modulating aqueous humor production or enhancing its drainage. Anti-inflammatory agents can mitigate ocular inflammation by suppressing immune responses.
The unique anatomy and physiology of the eye require tailored pharmacodynamic approaches. Understanding these interactions is essential for developing effective ocular medications that provide optimal therapeutic outcomes while minimizing side effects. Ocular pharmacodynamics plays a pivotal role in the design and optimization of drugs for various eye conditions, ensuring their efficacy and safety in maintaining ocular health.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India